Your browser doesn't support javascript.
loading
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials.
Sheng, Xinan; Wang, Lin; He, Zhisong; Shi, Yanxia; Luo, Hong; Han, Weiqing; Yao, Xin; Shi, Benkang; Liu, Jiyan; Hu, Changlu; Liu, Ziling; Guo, Hongqian; Yu, Guohua; Ji, Zhigang; Ying, Jianming; Ling, Yun; Yu, Shiying; Hu, Yi; Guo, Jianming; Fang, Jianmin; Zhou, Aiping; Guo, Jun.
Afiliação
  • Sheng X; Department of Genitourinary Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
  • Wang L; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • He Z; Department of Urology, Peking University First Hospital, Institute of Urology, National Urological Cancer Center of China, Peking University, Beijing, China.
  • Shi Y; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Luo H; Department of Genitourinary Oncology, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, China.
  • Han W; Department of Urology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine of Central South University, Changsha, China.
  • Yao X; Department of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Shi B; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
  • Liu J; Department of Biotherapy, Cancer Center, and National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Hu C; Department of Medical Oncology, Anhui Provincial Cancer Hospital, Hefei, China.
  • Liu Z; Department of Cancer Centre, First Hospital of Jilin University, Changchun, China.
  • Guo H; Department of Urology, Nanjing Drum Tower Hospital, Nanjing, China.
  • Yu G; Department of Medical Oncology, Weifang People's Hospital, Weifang, China.
  • Ji Z; Department of Urology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Ying J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer /Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Ling Y; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer /Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Yu S; Department of Urology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
  • Hu Y; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China.
  • Guo J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Fang J; RemeGen, Ltd, Yantai, China.
  • Zhou A; School of Life Science and Technology, Tongji University, Shanghai, China.
  • Guo J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Clin Oncol ; 42(12): 1391-1402, 2024 Apr 20.
Article em En | MEDLINE | ID: mdl-37988648
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Receptor ErbB-2 / Anticorpos Monoclonais / Neutropenia Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Receptor ErbB-2 / Anticorpos Monoclonais / Neutropenia Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article